XOMA Co. (NASDAQ:XOMAP) Short Interest Update

XOMA Co. (NASDAQ:XOMAPGet Free Report) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 1,000 shares, a decline of 33.3% from the May 15th total of 1,500 shares. Based on an average daily volume of 1,300 shares, the short-interest ratio is currently 0.8 days.

XOMA Price Performance

Shares of XOMAP opened at $25.45 on Friday. The firm has a fifty day simple moving average of $25.09 and a two-hundred day simple moving average of $24.90. XOMA has a twelve month low of $21.40 and a twelve month high of $25.98.

About XOMA

(Get Free Report)

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.

Recommended Stories

Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.